Dr. Si Chen | Materials Science | Best Researcher Award

Si Chen is a highly motivated and accomplished early-career researcher specializing in biomedical engineering, with a strong academic foundation in pharmaceutical sciences. Currently pursuing a Ph.D. at Tongji University, her research focuses on nanocatalytic medicine, single-atom catalysts, and antibacterial therapy. She has co-authored high-impact publications in prestigious journals such as Nano-Micro Letters and Advanced Materials, including a cover article and an ESI Highly Cited Paper. With hands-on experience in molecular biology, protein analysis, and translational cancer research, Si Chen has demonstrated both technical expertise and interdisciplinary collaboration. Her role in a national-level R&D project further highlights her capability in data management and research execution. Recognized with multiple academic awards and distinctions, she exemplifies both scientific rigor and academic dedication. Si Chen’s contributions position her as a strong candidate for research excellence awards, with continued potential for leadership in biomedical innovation and translational science.

Professional Profile 

Scopus Profile

Education

Si Chen has a solid educational foundation in pharmaceutical and biomedical sciences. She earned her MEng in Pharmaceutical Engineering from the University of Shanghai for Science and Technology, graduating with distinction and a strong GPA of 3.9/4.5. Her coursework included analytical and organic chemistry, toxicology, pharmacology, and pharmaceutical preparation technologies, equipping her with comprehensive knowledge of drug development and biological systems. Currently, she is pursuing a Ph.D. in Biomedical Engineering at Tongji University, focusing on nanocatalytic medicine, antibacterial mechanisms, and the application of single-atom catalysts in therapy. Her doctoral studies emphasize cutting-edge topics at the intersection of nanotechnology and biomedical applications, reflecting her transition from foundational pharmaceutical knowledge to advanced biomedical research. Si Chen’s academic progression demonstrates a consistent commitment to scientific excellence and interdisciplinary learning, positioning her well for a research career that bridges basic science with translational medical applications.

Professional Experience

Si Chen has cultivated extensive research experience through academic roles and collaborative scientific projects. She worked as a research assistant at Fudan University’s Department of Physiology and Biophysics from 2018 to 2021, where she contributed to several high-level biomedical studies. Her responsibilities included bacterial culture, protein purification, plasmid extraction, and Western blotting, giving her strong technical expertise in molecular biology. She also handled data organization for a national R&D project and was involved in budget and financial processes such as reimbursements—showcasing her project management skills. Earlier in her academic career, she participated in cancer research projects at Nanchang University, where she worked on drug interaction studies, mRNA and protein expression analysis, flow cytometry, and in vivo imaging. Through these diverse roles, she has demonstrated the ability to manage complex experiments and contribute to multidisciplinary teams. Her professional experience reflects a balanced profile of lab competence, analytical thinking, and research coordination.

Research Interest

Si Chen’s research interests lie at the intersection of nanotechnology, biomedical engineering, and pharmaceutical sciences. She is particularly focused on the development and application of single-atom catalysts and nanocatalytic medicine for antibacterial therapy. Her Ph.D. research at Tongji University explores how high iron-loading single-atom catalysts enhance reactive oxygen species (ROS) generation to combat bacterial infections, a novel and highly promising approach in antimicrobial research. She is also interested in piezocatalytic medicine, which leverages piezoelectric materials to trigger therapeutic responses—an emerging area that holds great potential for non-invasive biomedical applications. Additionally, her earlier work in cancer biology, including macrophage migration inhibitory factor (MIF) targeting and drug efficacy testing in vivo, highlights her interest in translational medicine. Si Chen’s research is defined by a drive to develop innovative, interdisciplinary solutions for critical healthcare challenges, particularly in antimicrobial resistance and cancer treatment, making her a valuable contributor to the field of biomedical innovation.

Award and Honor

Si Chen has received several notable awards that reflect her academic excellence, research impact, and extracurricular involvement. She was recognized with a Graduation with Distinction honor by the Shanghai Municipal Education Commission, highlighting her strong academic record during her undergraduate studies. Her research contributions have earned significant recognition, including co-authorship of a Highly Cited Paper in Advanced Materials—ranked in the top 1% by ESI—and a Most Viewed Paper Award from Wiley, placing her work among the top 10% in reader engagement. Si Chen was also the recipient of multiple student honors such as the Student Excellence Award and Student Leadership Award at the University of Shanghai for Science and Technology. Additionally, she served as an outstanding volunteer and actively participated in student leadership activities. These honors not only underline her academic and research capabilities but also illustrate her leadership, commitment, and service to the academic community.

Conclusion